Advertisement
Advertisement

CDMO

CDMO logo

Avid Bioservices Inc

12.40
USD
+0.015
+0.12%
Jan 17, 15:56 UTC -5
Closed
...

Avid Bioservices Inc Profile

About

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.

Info & Links

CEO

Nicholas S. Green

Headquarters

14191 Myford Road
Tustin, CA 92780, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

609

Employees

371

Avid Bioservices Inc Statistics

Valuation Measures

Market Capitalization2

790.68M

Enterprise Value

917.75M

Enterprise Value/EBITDA(ttm)

-142.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.28

Price to Book(mrq)

17.67

Price to Cash(ytd)

80.46

Profitability

Gross Margin(ttm)

6.99%

Operating Margin(ttm)

-20.85%

Profit Margin(ttm)

-92.49%

Return on Equity(ttm)

-33.18%

Return on Invested Capital(ttm)

-69.76%

Return on Assets(ttm)

-8.45%

Income Statement

Revenue(ttm)

150.44M

Revenue Per Share(ttm)

2.35

Gross Profit(ttm)

11.55M

EBITDA(ttm)3

-6.46M

Net Income Available to Common(ttm)

-152.05M

Diluted EPS(ttm)

-2.39

Share Statistics

Beta (5Y Monthly)

1.40

52-Week Change

128.27%

S&P 500 52-Week Change

25.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

63.96M

Dividend Yield

0.00%

Float4

62.01M

% Held by Insiders

3.05%

% Held by Institutions

97.16%

Balance Sheet

Total Cash(mrq)

33.41M

Total Cash Per Share(mrq)

0.52

Total Debt(mrq)

160.49M

Total Debt/Equity(mrq)

358.17%

Current Ratio(mrq)

1.30%

Quick Ratio(mrq)

0.92%

Book Value Per Share(mrq)

0.70

Cash Flow

Operating Cash Flow Per Share(ytd)

0.00

Free Cash Flow(ytd)

-4.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement